Viracta Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.30
|
-0.47
|
-0.17
|
-56.67%
|
|
2022-06-30
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2022-03-31
|
-0.31
|
-0.28
|
0.03
|
9.68%
|
|
2021-12-31
|
-0.43
|
-0.31
|
0.12
|
27.91%
|
|
2021-09-30
|
-0.31
|
-0.40
|
-0.09
|
-29.03%
|
|
2021-06-30
|
-0.24
|
-0.25
|
-0.01
|
-4.17%
|
|
2021-03-31
|
-0.21
|
-5.22
|
-5.01
|
-2385.71%
|
|
2020-12-31
|
-0.96
|
-0.73
|
0.23
|
23.96%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.03
|
|
2021-12-31
|
-6.18
|
|
2020-12-31
|
-5.59
|
|
2019-12-31
|
-10.50
|
|
2018-12-31
|
-3.81
|
|
2017-12-31
|
-1.52
|
|
2016-12-31
|
-2.50
|
|
2015-12-31
|
-2.94
|
|
2014-12-31
|
-29.22
|
|
2013-12-31
|
-40.20
|
|
2012-12-31
|
-63.00
|
|
2011-12-31
|
-26.40
|
|
2010-12-31
|
-85.80
|
|
2009-12-31
|
-1008.00
|
|
2007-12-31
|
-435.60
|
|
2006-12-31
|
-414.00
|
|
2005-12-31
|
-56946.68
|